Interaction of short peptides with FITC-labeled wheat histones and their complexes with deoxyribooligonucleotides.

Mechanism / theoretical grounding — not clinical validation.

Fedoreyeva LI, Smirnova TA, Kolomijtseva GY, Khavinson VKh, Vanyushin BF. Biochemistry (Mosc). 2013.

Organ: general-aging · Type: in-vitro · Peptides: Epitalon, Pinealon, Bronchogen, Testagen, AEDR, Pancragen

PMID: 23581987

Fluorescence quenching suggested Ala-Glu-Asp-Gly, Glu-Asp-Arg, Ala-Glu-Asp-Leu, Lys-Glu-Asp-Gly, Ala-Glu-Asp-Arg, and Lys-Glu-Asp-Trp bind wheat histones H1, H2B, H3, and H4 in a histone- and sequence-dependent way — histone biochemistry, not a trial.

Editorial summary of a 2013 original article in Biochemistry (Moscow). Peptide–histone fluorescence work on wheat histones. Public pages cite PubMed only. Read the paper: PMID 23581987.

Methods

The authors incubated FITC-labeled wheat histones H1, H2B, H3, and H4, and histone–deoxyribooligonucleotide complexes, with short peptides Ala-Glu-Asp-Gly (Epitalon), Glu-Asp-Arg (Pinealon), Ala-Glu-Asp-Leu (Bronchogen), Lys-Glu-Asp-Gly (Testagen), Ala-Glu-Asp-Arg (AEDR), and Lys-Glu-Asp-Trp (Pancragen). Binding was inferred from fluorescence quenching (Stern–Volmer constants). They compare single-stranded versus double-stranded and methylated versus unmethylated oligonucleotides. Assay concentrations belong in the primary text.

Findings

This paper is mechanistic or modeling evidence, not a clinical trial. The authors report that the peptides quench FITC-histone fluorescence and interpret this as binding at N-terminal histone regions (and, for core histones, at conformational sites, since they did not find homologous wheat core-histone sequences). Histone H1 preferred single-stranded oligonucleotides at C-terminal sites; core histones preferred double-stranded methylated oligonucleotides and methylated DNA. DNA or oligonucleotides in complex with histones could enhance or inhibit peptide binding.

This is wheat-histone fluorescence chemistry. It is not evidence of gene regulation in people. Follow the PMID.